Find a Commonwealth Resource
Fludeoxyglucose f18
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Fludeoxyglucose F18 is a radioactive diagnostic agent used in positron emission tomography (PET) scans to help detect and evaluate conditions like cancer, heart disease, and brain disorders. It's administered intravenously as an injection, with strengths ranging from 20-300 mCi/mL. Manufactured by UCSF Radiopharmaceutical Facility, it's a prescription drug approved under ANDA203902. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Fludeoxyglucose f18
Access the FDA dataset for Fludeoxyglucose f18 — ANDA 203942 submitted by Mylan Institutional LLC
Modified Apr 29, 2026